Department of Biomedical Engineering, Texas A&M University, College Station, Texas.
Department of Biomedical Engineering, Johns Hopkins University, Baltimore, Maryland.
Clin Cancer Res. 2019 Nov 1;25(21):6329-6338. doi: 10.1158/1078-0432.CCR-19-0854. Epub 2019 Jul 17.
In glioma surgery, it is critical to maximize tumor resection without compromising adjacent noncancerous brain tissue. Optical coherence tomography (OCT) is a noninvasive, label-free, real-time, high-resolution imaging modality that has been explored for glioma infiltration detection. Here, we report a novel artificial intelligence (AI)-assisted method for automated, real-time, detection of glioma infiltration at high spatial resolution. Volumetric OCT datasets were intraoperatively obtained from resected brain tissue specimens of 21 patients with glioma tumors of different stages and labeled as either noncancerous or glioma-infiltrated on the basis of histopathology evaluation of the tissue specimens (gold standard). Labeled OCT images from 12 patients were used as the training dataset to develop the AI-assisted OCT-based method for automated detection of glioma-infiltrated brain tissue. Unlabeled OCT images from the other 9 patients were used as the validation dataset to quantify the method detection performance.
Our method achieved excellent levels of sensitivity (∼100%) and specificity (∼85%) for detecting glioma-infiltrated tissue with high spatial resolution (16 μm laterally) and processing speed (∼100,020 OCT A-lines/second).
Previous methods for OCT-based detection of glioma-infiltrated brain tissue rely on estimating the tissue optical attenuation coefficient from the OCT signal, which requires sacrificing spatial resolution to increase signal quality, and performing systematic calibration procedures using tissue phantoms. By overcoming these major challenges, our AI-assisted method will enable implementing practical OCT-guided surgical tools for continuous, real-time, and accurate intraoperative detection of glioma-infiltrated brain tissue, facilitating maximal glioma resection and superior surgical outcomes for patients with glioma.
在脑胶质瘤手术中,最大限度地切除肿瘤而不损害邻近的正常脑组织至关重要。光学相干断层扫描(OCT)是一种非侵入性、无标记、实时、高分辨率的成像方式,已被用于胶质瘤浸润检测。在这里,我们报告了一种新的人工智能(AI)辅助方法,用于自动、实时、高空间分辨率检测胶质瘤浸润。术中从 21 名不同阶段脑胶质瘤患者的切除脑组织标本中获得体积 OCT 数据集,并根据组织标本的组织病理学评估将其标记为非癌性或胶质瘤浸润(金标准)。来自 12 名患者的标记 OCT 图像被用作训练数据集,以开发基于 AI 的 OCT 辅助方法,用于自动检测胶质瘤浸润性脑组织。来自其他 9 名患者的未标记 OCT 图像被用作验证数据集,以量化该方法的检测性能。
我们的方法在高空间分辨率(横向 16 μm)和处理速度(每秒约 100,020 个 OCT A 线)下,对检测胶质瘤浸润组织具有出色的灵敏度(约 100%)和特异性(约 85%)。
以前基于 OCT 的胶质瘤浸润脑组织检测方法依赖于从 OCT 信号估计组织光衰减系数,这需要牺牲空间分辨率来提高信号质量,并使用组织体模进行系统校准程序。通过克服这些主要挑战,我们的 AI 辅助方法将能够实现实用的 OCT 引导手术工具,用于连续、实时、准确地术中检测胶质瘤浸润性脑组织,促进最大限度地切除胶质瘤,为胶质瘤患者带来更好的手术效果。